← SynDRA
PT-2385
SynDRA canonical compound SYN0079903 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EPAS1 |
|---|
| Mechanism of action | hypoxia inducible factor inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- hypoxia inducible factor inhibitor
- EPAS1 INHIBITOR
- HIF1A INHIBITOR
Cross-references
Synonyms
- 79A
- CPD 10I
- PT2385
- ONBSHRSJOPSEGS-INIZCTEOSA-N
- UNII-6O16716DXP
- 6O16716DXP
- SCHEMBL16555810
- ZINC230453533
- AKOS030526641
- HY-12867
- PT2385,1672665-49-4, PT 2385,PT-2385
- Benzonitrile, 3-(((1S)-2,2-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl)oxy)-5-fluoro-
- 3-{[(1s)-2,2-Difluoro-1-Hydroxy-7-(Methylsulfonyl)-2,3-Dihydro-1h-Inden-4-Yl]oxy}-5-Fluorobenzonitrile
- 3-(((1S)-2,2-Difluoro-1-hydroxy-7-methanesulfonyl-2,3-dihydro-1hinden-4-yl)oxy)-5-fluorobenzonitrile
- RefChem:177078
- C17H12F3NO4S
- MFCD28963916
- orb1299450
- SCHEMBL29389356
- SCHEMBL30179065
- GTPL12707
- CHEBI:233314
- BDBM373008
- EX-A2855
- US9896418, Compound 163
- MK3795
- NSC787312
- s8352
- ZB1597
- EBC-519126
- MK-3795
- NSC-787312
- NCGC00387306-02
- AC-36340
- BS-16188
- DA-57206
- T7848
- D83665
- PT2385; PT-2385; PT 2385
Look up PT-2385 in the interactive SynDRA portal →